Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Fatty Liver, Nonalcoholic

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Fatty Liver, Nonalcoholic in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research Excerpts

ExcerptRelevanceReference
"The administration of a HFD induces insulin resistance in the liver sinusoidal endothelium, which is mediated, at least in part, through iNOS upregulation and can be prevented by the administration of metformin."3.77Insulin resistance and liver microcirculation in a rat model of early NAFLD. ( Abraldes, JG; Bosch, J; García-Pagán, JC; La Mura, V; Pasarín, M; Rodríguez-Vilarrupla, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pasarín, M1
Abraldes, JG1
Rodríguez-Vilarrupla, A1
La Mura, V1
García-Pagán, JC1
Bosch, J1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Fatty Liver, Nonalcoholic

ArticleYear
Insulin resistance and liver microcirculation in a rat model of early NAFLD.
    Journal of hepatology, 2011, Volume: 55, Issue:5

    Topics: Acetylcholine; Amidines; Animals; Benzylamines; Diet, High-Fat; Disease Models, Animal; Endothelium;

2011